Johnson & JohnsonJNJ

NYSE · USA · Segment 2 of 8 in the Medicine, pharma & life science value chain: Big pharma

Two businesses under one name: Innovative Medicine, which covers immunology and oncology drugs, and MedTech, which makes medical devices and surgical equipment.

Big pharma: Large, diversified pharmaceutical groups with broad portfolios across therapeutic areas.

Key metrics

Market cap

$630B

Price

$273.04

Today

+1.0%

Return YTD

+30.6%

Return 1Y

+51.0%

P/E

29.9

P/S

6.4

P/B

7.4

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

Big pharmaMedtech exposureOncologyMedtech

In the value chain

Products & services

Medicine (immunology/oncology)
Medical devices
Surgery

Competitors

Risks

Litigation (talc)
Patent cliff (Stelara)

Supply chain

Supplies →

McKessonMCK CencoraCOR

← Suppliers

Thermo Fisher ScientificTMO West Pharmaceutical ServicesWST

Full supply chain for JNJ →

Same segment: Big pharma

AbbVieABBV Merck & Co.MRK PfizerPFE Bristol Myers SquibbBMY ZoetisZTS

Compare JNJ

JNJ vs ABBV JNJ vs MRK JNJ vs PFE JNJ vs BMY JNJ vs ZTS

See where Johnson & Johnson sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →